Shortage outlook · all drugs · read October 2026
How long has Dextrose Monohydrate 10% been on the FDA shortage list?
Dextrose Monohydrate 10% has been on the FDA shortage list for 3 years and 1 month. 105 of the 397 listings measured since 2014 lasted at least that long. Of the 105 past listings that reached the same age, 93% were still listed 6 months later (90 listings measured), 82% were still listed 12 months later (75 listings measured) and 65% were still listed 24 months later (52 listings measured). These are counts of listings, not a forecast.
Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.
Dextrose Monohydrate 10% has been on the FDA shortage list for 3 years and 1 month (October 2023 to October 2026).
- 105 of the 397 listings measured since 2014 lasted at least that long.
- Of the 105 past listings that reached the same age, 93% were still listed 6 months later (90 listings measured), 82% were still listed 12 months later (75 listings measured) and 65% were still listed 24 months later (52 listings measured).
- None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.
The listing history, to scale
- Dextrose Monohydrate 10per InjectionListed since October 2023 · 3 years and 1 month
What past listings of this age did
Of past listings that had already run 3 years and 1 month, how many were still listed later?
FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset). Listing is the FDA's status, not a statement about any pharmacy.
Where can you go from this result?
This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.
- Sterile Water37 months
- Propranolol Hydrochloride36 months
- Liraglutide39 months
- Lisdexamfetamine (Vyvanse generics)39 months
To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.